B.P. Srinivasan

829 total citations
29 papers, 680 citations indexed

About

B.P. Srinivasan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, B.P. Srinivasan has authored 29 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in B.P. Srinivasan's work include Pancreatic function and diabetes (7 papers), Diabetes Treatment and Management (6 papers) and Retinal Diseases and Treatments (5 papers). B.P. Srinivasan is often cited by papers focused on Pancreatic function and diabetes (7 papers), Diabetes Treatment and Management (6 papers) and Retinal Diseases and Treatments (5 papers). B.P. Srinivasan collaborates with scholars based in India and United States. B.P. Srinivasan's co-authors include Sushma Srivastava, Suresh Kumar Gupta, Binit Kumar, Tapas Chandra Nag, Rohit Saxena, Ashish Kumar Sharma, Meenakshi Kanwar Chauhan, K Shilpa, Ashutosh N. Aggarwal and Apra Manral and has published in prestigious journals such as Biochemical Pharmacology, Human Reproduction and European Journal of Pharmacology.

In The Last Decade

B.P. Srinivasan

27 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.P. Srinivasan India 16 216 197 93 76 74 29 680
S. Sreenivasa Reddy India 16 186 0.9× 266 1.4× 77 0.8× 70 0.9× 34 0.5× 36 737
Osasenaga Macdonald Ighodaro Nigeria 7 274 1.3× 175 0.9× 105 1.1× 21 0.3× 67 0.9× 10 709
Eun Jin Sohn South Korea 18 131 0.6× 297 1.5× 106 1.1× 29 0.4× 45 0.6× 22 784
Mamdouh M. El‐Shishtawy Egypt 20 110 0.5× 391 2.0× 54 0.6× 161 2.1× 57 0.8× 49 1.1k
Yu Cao China 18 94 0.4× 345 1.8× 68 0.7× 30 0.4× 69 0.9× 70 865
Mungli Prakash India 12 79 0.4× 115 0.6× 86 0.9× 47 0.6× 32 0.4× 33 580
Prahalathan Pichavaram United States 16 78 0.4× 274 1.4× 57 0.6× 29 0.4× 74 1.0× 26 686
Weronika Wojnar Poland 14 96 0.4× 183 0.9× 72 0.8× 30 0.4× 20 0.3× 21 478
Manisha J. Oza India 15 120 0.6× 339 1.7× 73 0.8× 18 0.2× 46 0.6× 21 832
Masumi Kamiyama Japan 16 205 0.9× 394 2.0× 80 0.9× 53 0.7× 86 1.2× 25 1.2k

Countries citing papers authored by B.P. Srinivasan

Since Specialization
Citations

This map shows the geographic impact of B.P. Srinivasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.P. Srinivasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.P. Srinivasan more than expected).

Fields of papers citing papers by B.P. Srinivasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.P. Srinivasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.P. Srinivasan. The network helps show where B.P. Srinivasan may publish in the future.

Co-authorship network of co-authors of B.P. Srinivasan

This figure shows the co-authorship network connecting the top 25 collaborators of B.P. Srinivasan. A scholar is included among the top collaborators of B.P. Srinivasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.P. Srinivasan. B.P. Srinivasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Srinivasan, B.P., et al.. (2013). An experimental assessment of toxic potential of nanoparticle preparation of heavy metals in streptozotocin induced diabetes. Experimental and Toxicologic Pathology. 65(7-8). 1127–1135. 8 indexed citations
3.
Kumar, Binit, Suresh Kumar Gupta, B.P. Srinivasan, et al.. (2013). Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvascular Research. 87. 65–74. 127 indexed citations
4.
Kumar, Binit, Suresh Kumar Gupta, B.P. Srinivasan, et al.. (2013). Quercetin protects retinal vascular degeneration through anti-angiogenic mechanisms in STZ-induced diabetic rats. Investigative Ophthalmology & Visual Science. 54(15). 5561–5561.
5.
Gupta, Suresh Kumar, Binit Kumar, Tapas Chandra Nag, et al.. (2013). Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats. Molecular and Cellular Biochemistry. 388(1-2). 1–9. 23 indexed citations
7.
Gupta, Suresh Kumar, Binit Kumar, B.P. Srinivasan, et al.. (2012). Retinoprotective Effects of Moringa oleifera via Antioxidant, Anti-Inflammatory, and Anti-Angiogenic Mechanisms in Streptozotocin-Induced Diabetic Rats. Journal of Ocular Pharmacology and Therapeutics. 29(4). 419–426. 47 indexed citations
8.
Srinivasan, B.P., et al.. (2012). Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats. European Journal of Pharmaceutical Sciences. 47(2). 456–463. 25 indexed citations
10.
Sharma, Dinesh Kumar, Apra Manral, Vikas Saini, et al.. (2012). Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension. European Journal of Pharmacology. 691(1-3). 198–208. 35 indexed citations
11.
Kumar, Binit, Suresh Kumar Gupta, B.P. Srinivasan, et al.. (2012). Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats. Vascular Pharmacology. 57(5-6). 201–207. 54 indexed citations
12.
13.
Shukla, Ashutosh M. & B.P. Srinivasan. (2012). 16,17-Dihydro-17b-hydroxy isomitraphylline alkaloid as an inhibitor of DPP-IV, and its effect on incretin hormone and β-cell proliferation in diabetic rat. European Journal of Pharmaceutical Sciences. 47(2). 512–519. 11 indexed citations
16.
Sharma, Ashish Kumar, et al.. (2011). Cardioprotective activity of alcoholic extract of Tinospora cordifolia (Willd.) Miers in calcium chloride-induced cardiac arrhythmia in rats. Journal of Biomedical Research. 25(4). 280–286. 21 indexed citations
17.
Srinivasan, B.P., et al.. (2011). A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats. Biochemical Pharmacology. 83(2). 241–252. 26 indexed citations
18.
Srinivasan, B.P., et al.. (2010). A validated reverse phase HPLC and HPTLC method for estimation of Olmesartan Medoxomil in pharmaceutical dosage form. Der pharma chemica. 2(4). 103–112. 3 indexed citations
19.
Sharma, Ashish Kumar & B.P. Srinivasan. (2009). Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats. European Journal of Pharmaceutical Sciences. 38(5). 433–444. 53 indexed citations
20.
Chan, Wai‐Yee, Jimo Borjigin, Paul K.S. Chan, et al.. (1988). Pregnancy-specific β1 glycoprotein mRNA is present in placental as well as non-placental tissues. Human Reproduction. 3(5). 677–685. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026